See also this year's filing and all EDGAR filings for this company.
PDF Report 0001335105_2021_Lixte_Biotechnology_Holdings_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001335105, Lixte Biotechnology Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,228,475 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 216,524 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,919,798 |
| 9 | ResearchAndDevelopmentExpense | 1,254,190 |
| 10 | remainder_Expenses | 2,185 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 20,846 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 5,228,475 |
| 1 | Liabilities | 216,524 |
| 2 | Expenses | 3,176,173 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 5,011,951 |
| 5 | NetIncome | -3,155,327 |
| 6 | ComprehensiveNetIncome | -3,155,327 |
| 7 | BaseVar | 4,321,009 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.85 |
| 9 | EconomicCapitalRatio | 3.59 |
Edgar->Model Mapping
Feature Distribution
Change over Time
